HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Tie1 deletion inhibits tumor growth and improves angiopoietin antagonist therapy.

Abstract
The endothelial Tie1 receptor is ligand-less, but interacts with the Tie2 receptor for angiopoietins (Angpt). Angpt2 is expressed in tumor blood vessels, and its blockade inhibits tumor angiogenesis. Here we found that Tie1 deletion from the endothelium of adult mice inhibits tumor angiogenesis and growth by decreasing endothelial cell survival in tumor vessels, without affecting normal vasculature. Treatment with VEGF or VEGFR-2 blocking antibodies similarly reduced tumor angiogenesis and growth; however, no additive inhibition was obtained by targeting both Tie1 and VEGF/VEGFR-2. In contrast, treatment of Tie1-deficient mice with a soluble form of the extracellular domain of Tie2, which blocks Angpt activity, resulted in additive inhibition of tumor growth. Notably, Tie1 deletion decreased sprouting angiogenesis and increased Notch pathway activity in the postnatal retinal vasculature, while pharmacological Notch suppression in the absence of Tie1 promoted retinal hypervasularization. Moreover, substantial additive inhibition of the retinal vascular front migration was observed when Angpt2 blocking antibodies were administered to Tie1-deficient pups. Thus, Tie1 regulates tumor angiogenesis, postnatal sprouting angiogenesis, and endothelial cell survival, which are controlled by VEGF, Angpt, and Notch signals. Our results suggest that targeting Tie1 in combination with Angpt/Tie2 has the potential to improve antiangiogenic therapy.
AuthorsGabriela D'Amico, Emilia A Korhonen, Andrey Anisimov, Georgia Zarkada, Tanja Holopainen, René Hägerling, Friedemann Kiefer, Lauri Eklund, Raija Sormunen, Harri Elamaa, Rolf A Brekken, Ralf H Adams, Gou Young Koh, Pipsa Saharinen, Kari Alitalo
JournalThe Journal of clinical investigation (J Clin Invest) Vol. 124 Issue 2 Pg. 824-34 (Feb 2014) ISSN: 1558-8238 [Electronic] United States
PMID24430181 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Angiogenesis Inhibitors
  • Angiopoietin-1
  • Ligands
  • Receptors, Notch
  • Vascular Endothelial Growth Factor A
  • Receptor, TIE-1
  • Receptor, TIE-2
  • Vascular Endothelial Growth Factor Receptor-2
Topics
  • Angiogenesis Inhibitors (chemistry)
  • Angiopoietin-1 (antagonists & inhibitors, metabolism)
  • Animals
  • Apoptosis
  • Cell Survival
  • Endothelial Cells (cytology)
  • Endothelium, Vascular (metabolism)
  • Gene Deletion
  • Homozygote
  • Ligands
  • Mice
  • Mice, Transgenic
  • Neoplasm Transplantation
  • Neovascularization, Pathologic
  • Phenotype
  • Receptor, TIE-1 (genetics, physiology)
  • Receptor, TIE-2 (physiology)
  • Receptors, Notch (metabolism)
  • Retinal Vessels (pathology)
  • Signal Transduction
  • Time Factors
  • Vascular Endothelial Growth Factor A (metabolism)
  • Vascular Endothelial Growth Factor Receptor-2 (metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: